Skip to main content
SpringerLink
Log in
Book cover

Hughes Syndrome pp 29–40Cite as

Hemocytopenias in Antiphospholipid Syndrome

  • Chapter

  • 736 Accesses

Keywords

  • Systemic Lupus Erythematosus
  • Systemic Lupus Erythematosus Patient
  • Disseminate Intravascular Coagulation
  • Thrombotic Thrombocytopenic Purpura
  • Anticardiolipin Antibody

These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

This is a preview of subscription content, access via your institution.

Chapter
USD   29.95
Price excludes VAT (Canada)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (Canada)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (Canada)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (Canada)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Wilson WA, Gharavi AE, Koike T, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999;42:1309–1311.

    CrossRef  PubMed  CAS  Google Scholar 

  2. Cervera R, Piette JC, Font J, et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of diseases expression in a cohort of 1,000 patients. Arthritis Rheum 2002;46:1019–1027.

    CrossRef  PubMed  Google Scholar 

  3. Hughes GRV. The antiphospholipid syndrome. Ten years on. Lancet 1993;324:341–344.

    CrossRef  Google Scholar 

  4. Haj-Yahja S, Sherer Y, Blank M, et al. Anti-prothrombin antibodies cause thrombosis in an novel qualitative ex vivo animal model. Lupus 2003;12:364–369.

    CrossRef  PubMed  CAS  Google Scholar 

  5. Ziporen L, Polak-Charcon S, Korczyn DA, et al. Neurological dysfunction associated with antiphospholipid syndrome: histopathological brain findings in a mouse model. Clin Dev Immunol 2004;11:67–65.

    CrossRef  PubMed  Google Scholar 

  6. Finazzi G. The Italian Registry of antiphospholipid antibodies. Haematologica 1997;82:101–105.

    PubMed  CAS  Google Scholar 

  7. Vianna JL, Khamashta MA, Ordi-Ros J, et al. Comparison of the primary and secondary antiphospholipid syndrome: a European multicenter study of 114 patients. Am J Med 1994;96:3–9.

    CrossRef  PubMed  CAS  Google Scholar 

  8. Abu-Shakra M, Gladman DD, Urowitz MB, et al. Anticardiolipin antibodies in systemic lupus erythematosus: clinical and laboratory correlations. Am J Med 1995;99:624–628.

    CrossRef  PubMed  CAS  Google Scholar 

  9. Font J, Cervera R, Ramos-Casals M, et al. Clusters of clinical and immunologic features in systemic lupus erythematosus: analysis of 600 patients from a single center. Semin Arthritis Rheum 2004;33:217–230.

    CrossRef  PubMed  Google Scholar 

  10. Nojima J, Suehisa E, Kuratsune H, et al. High prevalence of thrombocytopenia in SLE patients with a high level of anticardiolipin antibodies combined with lupus anticoagulant. Am J Hematol 1998;58:55–60.

    CrossRef  PubMed  CAS  Google Scholar 

  11. McClain MT, Arbuckle MR, Heinlen LD, et al. The prevalence, onset, and clinical significance of antiphospholipid antibodies prior to diagnosis of systemic lupus erythematosus. Arthritis Rheum 2004;50:1226–1232.

    CrossRef  PubMed  Google Scholar 

  12. Briones M, Abshire T. Lupus anticoagulant in children. Curr Opin Hematol 2003;10:375–379.

    CrossRef  PubMed  CAS  Google Scholar 

  13. Ravelli A, Caporali R, Di Fuccia G, et al. Anticardiolipin antibodies in pediatric systemic lupus erythematosus. Arch Pediatr Adolesc Med 1994;148:398–402.

    PubMed  CAS  Google Scholar 

  14. Seaman DE, Londino AV Jr, Kwoh CK, et al. Antiphospholipid antibodies in pediatric Systemic Lupus Erythematosus. Pediatrics 1995;96:1040–1045.

    PubMed  CAS  Google Scholar 

  15. Von Scheven E, Glidden DV, Elder ME. Anti-β 2-glycoprotein I antibodies in pediatric systemic lupus erythematosus and antiphospholipid syndrome. Arthritis Rheum 2002;47:414–420.

    CrossRef  CAS  Google Scholar 

  16. Campos LMA, Kiss MH, D’Amico EA, et al. Antiphospholipid antibodies and antiphospholipid syndrome in 57 children and adolescents with systemic lupus erythematosus. Lupus 2003;12:820–826.

    CrossRef  PubMed  CAS  Google Scholar 

  17. La Rosa L, Covini G, Galperin C, et al. Anti-mitochondrial M5 type antibody represents one of the serological markers for anti-phospholipid syndrome distinct from anti-cardiolipin and anti-β 2-glycoprotein I antibodies. Clin Exp Immunol 1998;112:144–151.

    CrossRef  PubMed  Google Scholar 

  18. Font J, Lopez-Soto A, Cervera R, et al. Antibodies to thromboplastin in systemic lupus erythematosus: isotype distribution and clinical significance in a series of 92 patients. Thromb Res 1997;86:37–48.

    CrossRef  PubMed  CAS  Google Scholar 

  19. Munoz-Rodriguez FJ, Reverter JC, Font J, et al. Prevalence and clinical significance of antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome. Haematologica 2002;632–637.

    Google Scholar 

  20. Hayem G, Nicaise-Roland P, Palazzo E, et al. Non-oxidized low-density-lipoprotein (OxLDL) antibodies in systemic lupus erythematosus with and without antiphospholipid syndrome. Lupus 2001;10:346–351.

    CrossRef  PubMed  CAS  Google Scholar 

  21. Amengual O, Atsumi T, Khamashta MA, et al. Specificity of ELISA for antibody to beta 2-glycoprotein I in patients with antiphospholipid syndrome. Br J Rheumatol 1996;35:1239–1243.

    CrossRef  PubMed  CAS  Google Scholar 

  22. De Laat HB, Derksen RHWM, De Groot PG. Beta2-GPI, the playmaker of the antiphospholipid syndrome. Clin Immunol 2004;112:161–168.

    CrossRef  CAS  Google Scholar 

  23. Sanfilippo SS, Khamashta MA, Atsumi T, et al. Antibodies to β 2-glycoprotein I: a potential marker for clinical features of antiphospholipid antibody syndrome in patients with systemic lupus erythematosus. J Rheumatol 1998;25:2131–2134.

    PubMed  CAS  Google Scholar 

  24. Amoroso A, Mitterhofer AP, Del Porto F, et al. Antibodies to anionic phospholipids and anti-β 2-GPI: association with thrombosis and thrombocytopenia in systemic lupus erythematosus. Human Immunol 2003;64:265–273.

    CrossRef  CAS  Google Scholar 

  25. Caporali R, Longhi M, De Gennaro F, et al. Antiphospholipid antibody-associated thrombocytopenia in autoimmune dieases. Med Sci Res 1988;16:537–539.

    Google Scholar 

  26. Bertolaccini ML, Atsumi T, Escudero-Contreras A, et al. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus. J Rheumatol 2001;28:2637–2643.

    PubMed  CAS  Google Scholar 

  27. Lakos G, Kiss E, Regeczy N, et al. Isotype distribution and clinical relevance of anti-β 2-glycoprotein I antibodies: importance of IgA isotype. Clin Exp Immunol 1999;117:574–579.

    CrossRef  PubMed  CAS  Google Scholar 

  28. Sultan SM, Begum S, Isenberg DA. Prevalence, patterns of disease and outcome in patients with systemic lupus erythematosus who develop severe haematological problems. Rheumatology 2003;42:230–234.

    CrossRef  PubMed  CAS  Google Scholar 

  29. Galli M, Finazzi G, Barbui T. Thrombocytopenia in the antiphospholipid syndrome. Br J Haematol 1996;93:1–5.

    CrossRef  PubMed  CAS  Google Scholar 

  30. Harris EN, Gharavi AE, Hedge V, et al. Anticardiolipin antibodies in autoimmune thrombocytopenic purpura. Br J Haematol 1985;59:231–234.

    PubMed  CAS  Google Scholar 

  31. Out HJ, de Groot PG, van Vliet M, et al. Antibodies to platelets in patients with anti-phospholipid antibodies. Blood 1991;77:2655–2659.

    PubMed  CAS  Google Scholar 

  32. Bevers EM, Smeets EF, Confurius P, et al. Physiology of membrane lipid asymmetry. Lupus 1994;3:235–240.

    PubMed  CAS  Google Scholar 

  33. Robbins DL, Leung S, Miller-Blair DJ, et al. Effect of β 2-glycoprotein I complexes on production of thromboxane A2 by platelets from patients with antiphospholipid syndrome. J Rheumatol 1998;25:51–56.

    PubMed  CAS  Google Scholar 

  34. Nojima J, Suehisa E, Kuratsune H, et al. Platelet activation induced by combined effects of anticardiolipin and lupus anticoagulant IgG antibodies in patients with systemic lupus erythematosus. Thromb Haemost 1999;81:436–441.

    PubMed  CAS  Google Scholar 

  35. Galli M, Daldossi M, Barbui T. Anti-glycoprotein Ib/IX and IIb/IIIa antibodies in patients with antiphospholipid antibodies. Thromb Haemost 1994;71:571–575.

    PubMed  CAS  Google Scholar 

  36. Godeau B, Piette JC, Fromont P, et al. Specific antiplatelet glycoprotein autoantibodies are associated with the thrombocytopenia of primary antiphospholipid syndrome. Br J Haematol 1997;98:873–879.

    CrossRef  PubMed  CAS  Google Scholar 

  37. Fabris F, Steffan A, Cordiano I, et al. Specific antiplatelet autoantibodies in patients with antiphospholipid antibodies and thrombocytopenia. Eur J Haematol 1994;53:232–236.

    CrossRef  PubMed  CAS  Google Scholar 

  38. Macchi L, Rispal P, Clofent-Sanchez G, et al. Anti-platelet antibodies in patients with systemic lupus erythematosus and the primary antiphospholipid antibody syndrome: their relationship with the observed thrombocytopenia. Br J Haematol 1997;98:336–341.

    CrossRef  PubMed  CAS  Google Scholar 

  39. Michel M, Lee K, Piette JC, et al. Platelet autoantibodies and lupus-associated thrombocytopenia. Br J Haematol 2002;119:354–358.

    CrossRef  PubMed  Google Scholar 

  40. Lipp E, vov Felten A, Sax H, et al. Antibodies against platelet glycoproteins and antiphospholipid antibodies in autoimmune thrombocytopenia. Eur J Haematol 1998;60:283–288.

    CrossRef  PubMed  CAS  Google Scholar 

  41. Stasi S, Stipa E, Masi M, et al. Prevalence and clinical significance of elevated antiphospholipid antibodies in patients with idiopathic thrombocytopenic purpura. Blood 1994;84:4203–4208.

    PubMed  CAS  Google Scholar 

  42. Diz-Kucukkaya R, Hachanefioglu A, Yenerel M, et al. Antiphospholipid antibodies and antiphospholipid syndrome in patients presenting with immune thrombocytopenic purpura: a prospective cohort study. Blood 2001;98:1760–1764.

    CrossRef  PubMed  CAS  Google Scholar 

  43. Arepally G, Cines DB. Pathogenesis of heparin-induced thrombocytopenia and thrombosis. Autoimmune Rev 2002;1:125–132.

    CrossRef  CAS  Google Scholar 

  44. Arnout J. The pathogenesis of the antiphospholipid syndrome: a hypothesis based on parallelisms with heparin-induced thrombocytopenia. Thromb Haemost 1996;75:536–541.

    PubMed  CAS  Google Scholar 

  45. Lasne D, Saffroy R, Bachelot C, et al. Test for heparin-induced thrombocytopenia in primary antiphospholipid syndrome. Br J Rheumatol 1997;97:939.

    CAS  Google Scholar 

  46. Martinuzzo ME, Forestiero RR, Adamczuk Y, et al. Antiplatelet factor 4-heparin antibodies in patients with antiphospholipis antibodies. Throm Res 1999;15:271–279.

    CrossRef  Google Scholar 

  47. Bourhim M, Darnige L, Legallais C, et al. Anti-β 2-GPI antibodies recognizing platelet factor-4-heparin complex in antiphospholipid syndrome in patient substantiated with mouse model. J Mol Recognit 2003;16:125–130.

    CrossRef  PubMed  CAS  Google Scholar 

  48. Bizzaro N, Brandalise M. EDTA-dependent pseudothrombocytopenia. Association with antiplatelet and antiphospholipid antibodies. Am J Clin Pathol 1995;103:103–107.

    PubMed  CAS  Google Scholar 

  49. Montecucco C, Longhi M, Caporali R, et al. Hematological abnormalities associated with anticardiolipin antibodies. Haematologica 1989;74:195–204.

    PubMed  CAS  Google Scholar 

  50. Tincani A, Meroni PL, Brucato A, et al. Anti-phospholipid and anti-mitochondrial type M5 antibodies in systemic lupus erythematosus. Clin Exp Rheumatol 1985;3:321–326.

    PubMed  CAS  Google Scholar 

  51. Win N, Islam SI, Peterkin MA, et al. Positive direct antiglobulin test due to antiphospholipid antibodies in normal healthy blood donors. Vox Sang 1997;72:182–184.

    CrossRef  PubMed  CAS  Google Scholar 

  52. Asherson RA, Khamashta MA, Ordi-Ros J, et al. The “primary” antiphospholipid syndrome: major clinical and serological features. Medicine (Baltimore) 1989;68:366–374.

    PubMed  CAS  Google Scholar 

  53. Hazeltine M, Rauch J, Danoff D, et al. Antiphospholipid antibodies in systemic lupus erythematosus: evidence of an association with positive Coombs’ and hypocomplementemia. J Rheumatol 1998;15:80–86.

    Google Scholar 

  54. Kokori SIG, Ioannidis JPA, Voulgarelis M, et al. Autoimmune haemolytic anemia in patients with systemic lupus erythematosus. Am J Med 2000;108:198–204.

    CrossRef  PubMed  CAS  Google Scholar 

  55. Cervera R, Font J, Lopez-Soto A, et al. Isotype distribution of anticardiolipin antibodies in Systemic Lupus Erythematosus: prospective analysis of a series of 100 patients. Ann Rheum Dis 1990;49:109–113.

    CrossRef  PubMed  CAS  Google Scholar 

  56. Merkel PA, Chang Y, Pierangeli SS, et al. The prevalence and clinical associations of anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases. Am J Med 1996;101:576–583.

    CrossRef  PubMed  CAS  Google Scholar 

  57. Sthoeger Z, Sthoeger D, Green L, et al. The role of anticardiolipin autoantibodies in the pathogenesis of autoimmune hemolytic anemia in systemic lupus erythematosus. J Rheumatol 1993;20:2058–2061.

    PubMed  CAS  Google Scholar 

  58. Del Papa N, Meroni PL, Barcellini W, et al. Antiphospholipid antibodies cross-reacting with erythrocyte membranes. A case report. Clin Exp Rheumatol 1992;10:395–399.

    PubMed  Google Scholar 

  59. Cabral AR, Cabiedes J, Alarcon-Segovia D. Hemolytic anemia related to an IgM autoantibody to phosphatidylcholine that bind in vitro to stored and to bromelain-treated human erythrocytes. J Autoimmun 1990;3:773–787.

    PubMed  CAS  Google Scholar 

  60. Arnold LW, Haughton G. Autoantibodies to phosphatidylcholine. The murine antibromelain RBC response. Ann N Y Acad Sci 1992;651:354–359.

    PubMed  CAS  Google Scholar 

  61. Arfors L, Lefvert AK. Enrichment of antibodies against phospholipids in circulating immune complexes (CIC) in the anti-phospholipid syndrome (APLS). Clin Exp Immunol 1997;108:47–51.

    CrossRef  PubMed  CAS  Google Scholar 

  62. Guzman J, Cabral AR, Cabiedes J, et al. Antiphospholipid antibodies in patients with idiopathic autoimmune haemolytic anemia. Autoimmunity 1994;18:51–56.

    PubMed  CAS  Google Scholar 

  63. Lang B, Straub RH, Weber S, et al. Elevated anticardiolipin antibodies in autoimmune haemolytic anaemia irrespective of underlying systemic lupus erythematosus. Lupus 1997;6:652–655.

    PubMed  CAS  Google Scholar 

  64. Barzaghi N, Maurelli M, Emmi V, et al. Pulmonary thromboendoarterectomy in a patients with cryoagglutinins. J Cardiothorac Vasc Anesth 2000;14:447–448.

    CrossRef  PubMed  CAS  Google Scholar 

  65. Pullarkat V, Ngo M, Iabal S, et al. Detection of lupus anticoagulant identifies patients with autoimmune haemolytic anaemia at increased risk for venous thromboembolism. Br J Haematol 2002;118:1166–1169.

    CrossRef  PubMed  Google Scholar 

  66. Alarcon-Segovia D, Delezé M, Oria CV, et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medicine 1989;68:353–365.

    PubMed  CAS  Google Scholar 

  67. Deleze M, Oria CV, Alarcon-Segovia D. Occurrence of both hemolytic anemia and thrombocytopenic purpura (Evans’ syndrome) in systemic lupus erythematosus. Relationship to antiphospholipid antibodies. J Rheumatol 1998;15:611–615.

    Google Scholar 

  68. Avcin T, Jazbec J, Kuhar M, et al. Evans syndrome associated with antiphospholipid antibodies. J Pediatr Hematol Oncol 2003;25:755–756.

    PubMed  Google Scholar 

  69. Porta C, Caporali R, Montecucco C. Thrombotic thrombocytopenic purpura and autoimmunity: a tale of shadow and suspects. Haematologica 1999;84:260–269.

    PubMed  CAS  Google Scholar 

  70. Musio F, Bohen EM, Yuan CM, et al. Review of thrombotic thrombocytopenic purpura in the setting of systemic lupus erythematosus. Semin Arthritis Rheum 1998;28:1–19.

    CrossRef  PubMed  CAS  Google Scholar 

  71. Huang JJ, Chen MW, Sung JM, et al. Postpartum hemolytic uremic syndrome associated with antiphospholipid antibody. Nephrol Dial Transplant 1998;13:182–186.

    CrossRef  PubMed  CAS  Google Scholar 

  72. Asherson RA, Cervera R, Piette JC, et al. Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients. Medicine 1988;77:195–207.

    CrossRef  Google Scholar 

  73. Tsai HM. Advances in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura. J Am Soc Nephrol 2003;14:1072–1081.

    CrossRef  PubMed  Google Scholar 

  74. Knovich MA, Craver K, Matulis MD, et al. Simplified assay for VWF cleaving protease (ADAMTS13) activity and inhibitor in plasma. Am J Hematol 2004;76:286–290.

    CrossRef  PubMed  CAS  Google Scholar 

  75. Durand JM, Lefevre P, Kaplanski G, Soubeyrand J. Thrombotic microangiopathy and the antiphospholipid antibody syndrome. J Rheumatol 1991;18:1916–1918.

    PubMed  CAS  Google Scholar 

  76. Vasoo S, Thumboo J, Fong KY. Thrombotic thrombocytopenic purpura in systemic lupus erythematosus: disease activity and the use of cytotoxic drugs. Lupus 2002;11:443–450.

    CrossRef  PubMed  CAS  Google Scholar 

  77. Devinsky O, Petito CK, Alonso DR. Clinical and neuropathological findings in systemic lupus erythematosus: the role of vasculitis, heart emboli, and thrombotic thrombocytopenic purpura. Ann Neurol 1988;23:380–384.

    CrossRef  PubMed  CAS  Google Scholar 

  78. Porta C, Bobbio-Pallavicini E, Centurioni R, et al. Thrombotic thrombocytopenic purpura in systemic lupus erythematosus. J Rheumatol 2002;20:1625–1626.

    Google Scholar 

  79. Caramaschi P, Riccetti MM, Pasini AF, et al. Systemic lupus erythematosus and thrombotic thrombocytopenic purpura. Report of three cases and review of the literature. Lupus 1988;7:37–41.

    CrossRef  Google Scholar 

  80. Jorfen M, Callejas JL, Formiga F, et al. Fulminant thrombotic thrombocytopenic purpura in systemic lupus erythematosus. Scand J Rheumatol 1998;27:76–77.

    CrossRef  PubMed  CAS  Google Scholar 

  81. Espinosa G, Bucciarelli S, Cervera R, et al. Thrombotic microangiopathic haemolytic anemia and antiphospholipid antibodies. Ann Rheum Dis 2004;63:730–736.

    CrossRef  PubMed  CAS  Google Scholar 

  82. Trent K, Neustater BR, Lottenberg R. Chronic thrombotic thrombocytopenic purpura and antiphospholipid antibodies: A report of two cases. Am J Haematol 1997;54:155–159.

    CrossRef  CAS  Google Scholar 

  83. Ardiles LG, Olavarria F, Elgueta M, et al. Anticardiolipin antibodies in classic pediatric hemolyticuremic syndrome: a possible pathogenic role. Nephron 1998;78:278–283.

    CrossRef  PubMed  CAS  Google Scholar 

  84. Sinha J, Chowdhry I, Sedan S, et al. Bone marrow necrosis and refractory HELLP syndrome in a patient with catastrophic antiphospholipid syndrome. J Rheumatol 2002;29:195–197.

    PubMed  Google Scholar 

  85. Neuwelt CM, Daikh DI, Linfoot JA, et al. Catastrophic antiphospholipid syndrome: response to repeated plasmpheresis over three years. Arthritis Rheum 1997;40:1534–1539.

    PubMed  CAS  Google Scholar 

  86. Falcini F, Taccetti G, Ermini M, et al. Catstrophic antiphospholipid antibody syndrome in pediatric systemic lupus erythematosus. J Rheumatol 1997;24:389–392.

    PubMed  CAS  Google Scholar 

  87. Gamba G, Montani N, Montecucco C, et al. Purpura fulminans as clinical manifestation of atypical SLE with antiphospholipid antibodies: a case report. Haematologica 1991;76:426–428.

    PubMed  CAS  Google Scholar 

  88. Arvieux J, Jacob MC, Roussel B, et al. Neutrophil activation by anti-beta 2 glycoprotein I monoclonal antibodies via Fc gamma receptor II. J Leukoc Biol 1995;57:387–394.

    PubMed  CAS  Google Scholar 

  89. Moore J, Ma DD, Concannon A. Non-malignant bone marrow necrosis: a report of two cases. Pathology 1998;30:318–320.

    CrossRef  PubMed  CAS  Google Scholar 

  90. De Ceulaer K, Khamashta MA, Harris EN, et al. Antiphospholipid antibodies in homozygous sickle cell disease. Ann Rheum Dis 1992;51:671–672.

    PubMed  Google Scholar 

  91. Kucuk O, Gilman-Sachs A, Beaman K, et al. Antiphospholipid antibodies in sickle cell disease. Am J Haematol 1993;42:380–383.

    CAS  Google Scholar 

  92. Yeghen T, Benjamin S, Boyd O, et al. Sickle cell anemia, right atrial thrombosis, and the antiphospholipid antibody. Am J Hematol 1995;50:46–48.

    PubMed  CAS  Google Scholar 

  93. Hassoun A, Al-Kadhimi Z, Cervia J. HIV infection and antiphospholipid antibody: literature review and link to the antiphspholipid sindrome. AIDS Patient Care STDS 2004;18:333–340.

    CrossRef  PubMed  Google Scholar 

  94. Palomo I, Alarcon M, Sepulveda C, et al. Prevalence of antiphospholipid antibodies in HIV-infected Chilean patients. J Clin Lab Anal 2003;17:209–215.

    CrossRef  PubMed  CAS  Google Scholar 

  95. Cacoub P, Musset L, Amoura Z, et al. Anticardiolipin, anti-β 2-glycoprotein I, and antinucleosome antibodies in hepatitis C virus infection and mixed cryoglobulinemia. Multivirc group. J Rheumatol 1997;24:2139–2144.

    PubMed  CAS  Google Scholar 

  96. Ordi-Ros J, Villareal J, Monegal F, et al. Anticardiolipin antibodies in patients with chronic hepatitis C virus infection: characterization in relation to antiphospholipid syndrome. Clin Diagn Lab Immunol 2000;7:241–244.

    CrossRef  PubMed  CAS  Google Scholar 

  97. Leroy V, Arvieux J, Jacob MC, et al. Prevalence and significance of anticardiolipin, anti-β 2 glycoprotein I and anti-prothrombin antibodies in chronic hepatitis C. Br J Haematol 1998;101:468–474.

    CrossRef  PubMed  CAS  Google Scholar 

  98. Ramos-Casals M, Cervera R, Lagrutta M, et al. Clinical features related to antiphospholipid syndrome in patients with chronic viral infections (hepatitis C virus/HIV infection): description of 82 cases. Clin Infect Dis 2004;38:1009–1016.

    CrossRef  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Servizio di Reumatologia, University of Pavia, IRCCS Policlinico S. Matteo, Pavia, Italy

    Carlomaurizio Montecucco MD & Roberto Caporali MD

Authors
  1. Carlomaurizio Montecucco MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Roberto Caporali MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Lupus Research Unit, St Thomas’ Hospital, London, UK

    M. A. Khamashta MD, FRCP, PhD (Deputy Head) (Deputy Head)

Rights and permissions

Reprints and Permissions

Copyright information

© 2006 Springer-Verlag London Limited

About this chapter

Cite this chapter

Montecucco, C., Caporali, R. (2006). Hemocytopenias in Antiphospholipid Syndrome. In: Khamashta, M.A. (eds) Hughes Syndrome. Springer, London. https://doi.org/10.1007/1-84628-009-5_4

Download citation

  • DOI: https://doi.org/10.1007/1-84628-009-5_4

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-85233-873-2

  • Online ISBN: 978-1-84628-009-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

search

Navigation